WARNING: This product is for research use only, not for human or veterinary use.
Safotibant, also known as LF-22-0542, is a bradykinin B1 receptor antagonist which was under development for the topical treatment of diabetic macular oedema.
Price and Availability
Safotibant is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to email@example.com to inquire quote.
MedKoo Cat#: 319753
Chemical Formula: C25H34N4O5S
Exact Mass: 502.225
Molecular Weight: 502.63
Elemental Analysis: C, 59.74; H, 6.82; N, 11.15; O, 15.92; S, 6.38
LF-22-0542; LF22-0542; LF 22-0542; LF-220542; LF220542; LF 220542; Safotibant.
>98% (or refer to the Certificate of Analysis)
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Soluble in DMSO, not in water
>2 years if stored properly
This drug may be formulated in DMSO
Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
Harmonized System Code: